News
- Author:
- Walter Alexander
Publish date: May 12, 2021
The combination of paclitaxel and carboplatin with concurrent 41.4 Gy radiotherapy before surgery seems safe in t...
News
- Author:
- Walter Alexander
Publish date: April 29, 2021
Sintilimab improved overall and progression-free survival, when compared with docetaxel.
News
- Author:
- Walter Alexander
Publish date: April 21, 2021
Tislelizumab was associated with better outcomes in patients with locally advanced or metastatic non–small cell lung cancer.
News
- Author:
- Walter Alexander
Publish date: April 19, 2021
Prior studies suggested that antibiotics reduce the efficacy of immunotherapy.
News
- Author:
- Walter Alexander
Publish date: April 15, 2021
Tebentafusp prolonged overall survival by nearly 6 months.
News
- Author:
- Walter Alexander
Publish date: April 14, 2021
The vaccine consists of patient-specific synthetic neoantigen peptides and is given to patients in the adjuvant setting.
News
- Author:
- Walter Alexander
Publish date: April 13, 2021
In men at the highest risk of dying from prostate cancer, a healthy lifestyle cut the risk of fatal disease in half.
News
- Author:
- Walter Alexander
Publish date: March 24, 2021
The prevalence of SHS exposure among nonsmokers declined from 87.5% to 25.3% between 1988 and 2012.
News
- Author:
- Walter Alexander
Publish date: March 18, 2021
The WHO’s goal is to have HPV vaccines delivered to 90% of all adolescent girls by 2030.
News
- Author:
- Walter Alexander
Publish date: March 5, 2021
Another drop in the rates of adult vaccinations may have occurred due to the surge in COVID-19 infections in the fall of 2020.
News
- Author:
- Walter Alexander
Publish date: February 26, 2021
Matching baseline tumor subtypes to SCLC therapy may enhance the depth and duration of response.
News
- Author:
- Walter Alexander
Publish date: February 10, 2021
Activity against respiratory pathogens has been demonstrated for interferon lambda-1, a type III interferon.
News
- Author:
- Walter Alexander
Publish date: January 19, 2021
Overall, 24% of ED visits were deemed preventable, and 10% were considered unnecessary.
News
- Author:
- Walter Alexander
Publish date: December 24, 2020
Findings could lead to better monitoring of comorbidities and deeper understanding of disease burden and AD pathophysiology, the authors write.
News
- Author:
- Walter Alexander
Publish date: December 22, 2020
Phase 3 study shows superior event-free survival and reduced toxicities for blinatumomab versus chemotherapy.
